Clostridium dalinum
Clostridium dalinum has one identified study in the indexed literature: a 2025 animal model investigation examining gut and metabolic parameters in the context of microplastic exposure, looking at microbiota-metabolism-barrier interactions. This is a single preclinical study in animals, and the results cannot be extrapolated to human health without further research. Clostridium as a genus includes both commensal and pathogenic species; the safety profile of C. dalinum specifically as a probiotic candidate has not been established in humans, and this organism should be considered highly preliminary in that context. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 1 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
3 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41030387 →A probiotic for preventing microplastic toxicity: Clostridium dalinum mitigates microplastic-induced damage via microbiota-metabolism-barrier interactions· Current Research in Food Science · 2025